Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chronic Obstructive Pulmonary Diseases is Scopus-indexed (Q2, CiteScore 4.1), WoS SCIE. Published by COPD Foundation.
Checked against the index lists dated .
ISSN 2372-952XVerify ISSN ↗
Publisher: COPD Foundation
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 66 / 165 | 60th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q2, CiteScore 4.1.
Chronic Obstructive Pulmonary Diseases is Q2 in Pulmonary and Respiratory Medicine (rank 66 of 165), by CiteScore 2025.
Chronic Obstructive Pulmonary Diseases is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.1, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.909, quartile Q2, with an H-index of 26.
Chronic Obstructive Pulmonary Diseases is published by COPD Foundation. Its ISSN is 2372-952X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Chronic Obstructive Pulmonary Diseases has an h-index of 33 and a 2-year mean of 1.58 citations per paper (OpenAlex). Its Scopus CiteScore is 4.1, quartile Q2. On 2-year citations it ranks #72 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Chronic Obstructive Pulmonary Diseases published 52 papers in 2025; its busiest recent year was 2020 with 63. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from United States (57.7%), China (13.5%) and United Kingdom (7.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.